(Q39096171)

English

Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study

scientific article published on 16 December 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study (English)

1 reference

Europe PubMed Central

9 September 2017

multicenter clinical trial

0 references

Behçet's disease

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

14

1 reference

Europe PubMed Central

9 September 2017

Silvana Guerriero

object named as

Silvana Guerriero

6

0 references

Claudia Fabiani

object named as

Claudia Fabiani

1

0 references

object named as

Giacomo Emmi

3

0 references

11

object named as

Mauro Galeazzi

1 reference

Europe PubMed Central

9 September 2017

10

object named as

Bruno Frediani

1 reference

Europe PubMed Central

9 September 2017

Gian Marco Tosi

13

object named as

Gian Marco Tosi

1 reference

Europe PubMed Central

9 September 2017

Giuseppe Lopalco

4

object named as

Giuseppe Lopalco

1 reference

Europe PubMed Central

9 September 2017

Lorenzo Vannozzi

5

object named as

Lorenzo Vannozzi

1 reference

Europe PubMed Central

9 September 2017

Daniela Bacherini

8

object named as

Daniela Bacherini

1 reference

Europe PubMed Central

9 September 2017

Florenzo Iannone

12

object named as

Florenzo Iannone

1 reference

Europe PubMed Central

9 September 2017

author name string

Antonio Vitale

2

1 reference

Europe PubMed Central

9 September 2017

Stefano Gentileschi

7

1 reference

Europe PubMed Central

9 September 2017

Rossella Franceschini

9

1 reference

Europe PubMed Central

9 September 2017

publication date

16 December 2016

1 reference

Europe PubMed Central

9 September 2017

Clinical Rheumatology

1 reference

Europe PubMed Central

9 September 2017

36

1 reference

Europe PubMed Central

9 September 2017

1

1 reference

Europe PubMed Central

9 September 2017

191-197

1 reference

Europe PubMed Central

9 September 2017

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Controversies in Behçet disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

EULAR recommendations for the management of Behçet disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Local (topical and intraocular) therapy for ocular Adamantiades-Behçet's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Management of Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Pathogenesis of Behçet's disease: autoinflammatory features and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Resistant Behçet disease responsive to anakinra

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Cutting Edge: IL-1 Receptor Signaling is Critical for the Development of Autoimmune Uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Anakinra treatment in drug-resistant Behcet’s disease: a case series

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α

1 reference

https://api.crossref.org/works/10.1007%2FS10067-016-3506-4

21 January 2018

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful use of canakinumab in a patient with resistant Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1 Inhibition in Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behçet's syndrome: a critical digest of the 2013-2014 literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of anakinra in refractory Behçet's disease sacroiliitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiricism in managing Behçet's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anakinra for resistant Behçet uveitis: why not?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27981463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-016-3506-4

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39096171&oldid=1807308615"